Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Molecular Imaging of Smoke-Induced Changes in Nuclear Factor-Kappa B Expression in Murine Tissues Including the Lung.

Syrkina O, Hales CH, Bonab AA, Hamrahi V, Paul K, Jung WJ, Tompkins RG, Fischman AJ, Carter EA.

J Burn Care Res. 2016 Nov/Dec;37(6):335-342.

PMID:
27437954
2.

Practical Radiosynthesis and Preclinical Neuroimaging of [11C]isradipine, a Calcium Channel Antagonist.

Rotstein BH, Liang SH, Belov VV, Livni E, Levine DB, Bonab AA, Papisov MI, Perlis RH, Vasdev N.

Molecules. 2015 May 26;20(6):9550-9. doi: 10.3390/molecules20069550.

3.

Synthesis and preclinical evaluation of [¹⁸F]FCHC for neuroimaging of fatty acid amide hydrolase.

Shoup TM, Bonab AA, Wilson AA, Vasdev N.

Mol Imaging Biol. 2015 Apr;17(2):257-63. doi: 10.1007/s11307-014-0789-1.

PMID:
25273322
4.

Initial in vivo PET imaging of 5-HT1A receptors with 3-[(18)F]mefway.

Wooten DW, Hillmer AT, Murali D, Barnhart TE, Thio JP, Bajwa AK, Bonab AA, Normandin MD, Schneider ML, Mukherjee J, Christian BT.

Am J Nucl Med Mol Imaging. 2014 Aug 15;4(5):483-9. eCollection 2014.

5.

Single hind limb burn injury to mice alters nuclear factor-κB expression and [¹⁸F] 2-fluoro-2-deoxy-D-glucose uptake.

Carter EA, Hamrahi V, Paul K, Bonab AA, Jung W, Tompkins RG, Fischman AJ.

J Burn Care Res. 2014 Nov-Dec;35(6):e373-8. doi: 10.1097/BCR.0000000000000035.

6.

Bias atlases for segmentation-based PET attenuation correction using PET-CT and MR.

Ouyang J, Chun SY, Petibon Y, Bonab AA, Alpert N, Fakhri GE.

IEEE Trans Nucl Sci. 2013 Oct 1;60(5):3373-3382.

7.

Simvastatin reduces burn injury-induced splenic apoptosis via downregulation of the TNF-α/NF-κB pathway.

Zhao G, Yu YM, Kaneki M, Bonab AA, Tompkins RG, Fischman AJ.

Ann Surg. 2015 May;261(5):1006-12. doi: 10.1097/SLA.0000000000000764.

8.

Membrane potential-dependent uptake of 18F-triphenylphosphonium--a new voltage sensor as an imaging agent for detecting burn-induced apoptosis.

Zhao G, Yu YM, Shoup TM, Elmaleh DR, Bonab AA, Tompkins RG, Fischman AJ.

J Surg Res. 2014 May 15;188(2):473-9. doi: 10.1016/j.jss.2014.01.011. Epub 2014 Jan 11.

9.

Myocardial defect detection using PET-CT: phantom studies.

Mananga ES, El Fakhri G, Schaefferkoetter J, Bonab AA, Ouyang J.

PLoS One. 2014 Feb 5;9(2):e88200. doi: 10.1371/journal.pone.0088200. eCollection 2014.

10.

Effect of exercise on burn-induced changes in tissue-specific glucose metabolism.

Carter EA, Paul K, Bonab AA, Tompkins RG, Fischman AJ.

J Burn Care Res. 2014 Nov-Dec;35(6):470-3. doi: 10.1097/BCR.0000000000000036.

11.

Simultaneous 99mTc-MDP/123I-MIBG tumor imaging using SPECT-CT: phantom and constructed patient studies.

Rakvongthai Y, El Fakhri G, Lim R, Bonab AA, Ouyang J.

Med Phys. 2013 Oct;40(10):102506. doi: 10.1118/1.4820977.

12.

Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass.

Saeidi N, Meoli L, Nestoridi E, Gupta NK, Kvas S, Kucharczyk J, Bonab AA, Fischman AJ, Yarmush ML, Stylopoulos N.

Science. 2013 Jul 26;341(6144):406-10. doi: 10.1126/science.1235103.

13.

Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects.

Spencer TJ, Biederman J, Faraone SV, Madras BK, Bonab AA, Dougherty DD, Batchelder H, Clarke A, Fischman AJ.

Biol Psychiatry. 2013 Jul 15;74(2):84-9. doi: 10.1016/j.biopsych.2012.11.010. Epub 2012 Dec 27.

14.

Brown adipose tissue and its modulation by a mitochondria-targeted peptide in rat burn injury-induced hypermetabolism.

Yo K, Yu YM, Zhao G, Bonab AA, Aikawa N, Tompkins RG, Fischman AJ.

Am J Physiol Endocrinol Metab. 2013 Feb 15;304(4):E331-41. doi: 10.1152/ajpendo.00098.2012. Epub 2012 Nov 20.

15.

Isolation rearing significantly perturbs brain metabolism in the thalamus and hippocampus.

Bonab AA, Fricchione JG, Gorantla S, Vitalo AG, Auster ME, Levine SJ, Scichilone JM, Hegde M, Foote W, Fricchione GL, Denninger JW, Yarmush DM, Fischman AJ, Yarmush ML, Levine JB.

Neuroscience. 2012 Oct 25;223:457-64. doi: 10.1016/j.neuroscience.2012.07.032. Epub 2012 Jul 24.

PMID:
22835621
16.

5-HT2 receptor distribution shown by [18F] setoperone PET in high-functioning autistic adults.

Beversdorf DQ, Nordgren RE, Bonab AA, Fischman AJ, Weise SB, Dougherty DD, Felopulos GJ, Zhou FC, Bauman ML.

J Neuropsychiatry Clin Neurosci. 2012 Spring;24(2):191-7. doi: 10.1176/appi.neuropsych.11080202.

PMID:
22772667
17.

Understanding the central pharmacokinetics of spheroidal oral drug absorption system (SODAS) dexmethylphenidate: a positron emission tomography study of dopamine transporter receptor occupancy measured with C-11 altropane.

Spencer TJ, Bonab AA, Dougherty DD, Mirto T, Martin J, Clarke A, Fischman AJ.

J Clin Psychiatry. 2012 Mar;73(3):346-52. doi: 10.4088/JCP.10m06393. Epub 2011 Nov 1.

PMID:
22154896
18.

Association of heat production with 18F-FDG accumulation in murine brown adipose tissue after stress.

Carter EA, Bonab AA, Paul K, Yerxa J, Tompkins RG, Fischman AJ.

J Nucl Med. 2011 Oct;52(10):1616-20. doi: 10.2967/jnumed.111.090175. Epub 2011 Sep 13.

19.

Evaluation of the antioxidant peptide SS31 for treatment of burn-induced insulin resistance.

Carter EA, Bonab AA, Goverman J, Paul K, Yerxa J, Tompkins RG, Fischman AJ.

Int J Mol Med. 2011 Oct;28(4):589-94. doi: 10.3892/ijmm.2011.752. Epub 2011 Jul 19.

20.

Effects of burn injury, cold stress and cutaneous wound injury on the morphology and energy metabolism of murine brown adipose tissue (BAT) in vivo.

Carter EA, Bonab AA, Hamrahi V, Pitman J, Winter D, Macintosh LJ, Cyr EM, Paul K, Yerxa J, Jung W, Tompkins RG, Fischman AJ.

Life Sci. 2011 Jul 18;89(3-4):78-85. doi: 10.1016/j.lfs.2011.04.014. Epub 2011 May 4.

21.

Iodine-124 as a label for pharmacological PET imaging.

Belov VV, Bonab AA, Fischman AJ, Heartlein M, Calias P, Papisov MI.

Mol Pharm. 2011 Jun 6;8(3):736-47. doi: 10.1021/mp100358f. Epub 2011 Apr 6.

PMID:
21361362
22.

A positron emission tomography study examining the dopaminergic activity of armodafinil in adults using [¹¹C]altropane and [¹¹C]raclopride.

Spencer TJ, Madras BK, Bonab AA, Dougherty DD, Clarke A, Mirto T, Martin J, Fischman AJ.

Biol Psychiatry. 2010 Nov 15;68(10):964-70. doi: 10.1016/j.biopsych.2010.08.026.

PMID:
21035624
23.

Stem cells and burns: review and therapeutic implications.

Butler KL, Goverman J, Ma H, Fischman A, Yu YM, Bilodeau M, Rad AM, Bonab AA, Tompkins RG, Fagan SP.

J Burn Care Res. 2010 Nov-Dec;31(6):874-81. doi: 10.1097/BCR.0b013e3181f9353a. Review.

PMID:
20859216
24.

Effect of simvastatin on burn-induced alterations in tissue specific glucose metabolism: implications for burn associated insulin resistance.

Bonab AA, Carter EA, Paul K, Kaneki M, Yu YM, Tompkins RG, Fischman AJ.

Int J Mol Med. 2010 Sep;26(3):311-6.

25.

A PET study examining pharmacokinetics and dopamine transporter occupancy of two long-acting formulations of methylphenidate in adults.

Spencer TJ, Bonab AA, Dougherty DD, Martin J, McDonnell T, Fischman AJ.

Int J Mol Med. 2010 Feb;25(2):261-5.

PMID:
20043136
26.

A combined [11C]diprenorphine PET study and fMRI study of acupuncture analgesia.

Dougherty DD, Kong J, Webb M, Bonab AA, Fischman AJ, Gollub RL.

Behav Brain Res. 2008 Nov 3;193(1):63-8. doi: 10.1016/j.bbr.2008.04.020. Epub 2008 May 2.

27.

Comparison of standard-dose vs low-dose attenuation correction CT on image quality and positron emission tomographic attenuation correction.

Krishnasetty V, Bonab AA, Fischman AJ, Halpern EF, Aquino SL.

J Am Coll Radiol. 2008 Apr;5(4):579-84. doi: 10.1016/j.jacr.2007.12.007.

PMID:
18359446
28.

Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates.

Voss SD, Smith SV, DiBartolo N, McIntosh LJ, Cyr EM, Bonab AA, Dearling JL, Carter EA, Fischman AJ, Treves ST, Gillies SD, Sargeson AM, Huston JS, Packard AB.

Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17489-93. Epub 2007 Oct 22.

29.

Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane.

Spencer TJ, Biederman J, Madras BK, Dougherty DD, Bonab AA, Livni E, Meltzer PC, Martin J, Rauch S, Fischman AJ.

Biol Psychiatry. 2007 Nov 1;62(9):1059-61. Epub 2007 May 23.

30.

PET/CT imaging for treatment verification after proton therapy: a study with plastic phantoms and metallic implants.

Parodi K, Paganetti H, Cascio E, Flanz JB, Bonab AA, Alpert NM, Lohmann K, Bortfeld T.

Med Phys. 2007 Feb;34(2):419-35.

31.

Dopamine transporter (DAT) inhibitors alleviate specific parkinsonian deficits in monkeys: association with DAT occupancy in vivo.

Madras BK, Fahey MA, Goulet M, Lin Z, Bendor J, Goodrich C, Meltzer PC, Elmaleh DR, Livni E, Bonab AA, Fischman AJ.

J Pharmacol Exp Ther. 2006 Nov;319(2):570-85. Epub 2006 Aug 2.

PMID:
16885433
32.

Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro.

Madras BK, Xie Z, Lin Z, Jassen A, Panas H, Lynch L, Johnson R, Livni E, Spencer TJ, Bonab AA, Miller GM, Fischman AJ.

J Pharmacol Exp Ther. 2006 Nov;319(2):561-9. Epub 2006 Aug 2.

PMID:
16885432
33.

Decreased striatal D1 binding as measured using PET and [11C]SCH 23,390 in patients with major depression with anger attacks.

Dougherty DD, Bonab AA, Ottowitz WE, Livni E, Alpert NM, Rauch SL, Fava M, Fischman AJ.

Depress Anxiety. 2006;23(3):175-7.

PMID:
16528700
34.

PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate.

Spencer TJ, Biederman J, Ciccone PE, Madras BK, Dougherty DD, Bonab AA, Livni E, Parasrampuria DA, Fischman AJ.

Am J Psychiatry. 2006 Mar;163(3):387-95.

PMID:
16513858
35.

Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG.

Pellegrino D, Bonab AA, Dragotakes SC, Pitman JT, Mariani G, Carter EA.

J Nucl Med. 2005 Sep;46(9):1522-30.

36.

In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter.

Spencer TJ, Biederman J, Madras BK, Faraone SV, Dougherty DD, Bonab AA, Fischman AJ.

Biol Psychiatry. 2005 Jun 1;57(11):1293-300. Review.

PMID:
15950001
37.
38.

Non-amine-based dopamine transporter (reuptake) inhibitors retain properties of amine-based progenitors.

Madras BK, Fahey MA, Miller GM, De La Garza R, Goulet M, Spealman RD, Meltzer PC, George SR, O'Dowd BF, Bonab AA, Livni E, Fischman AJ.

Eur J Pharmacol. 2003 Oct 31;479(1-3):41-51.

PMID:
14612136
39.

A second-generation 99m technetium single photon emission computed tomography agent that provides in vivo images of the dopamine transporter in primate brain.

Meltzer PC, Blundell P, Zona T, Yang L, Huang H, Bonab AA, Livni E, Fischman A, Madras BK.

J Med Chem. 2003 Jul 31;46(16):3483-96.

PMID:
12877586
40.

[(11)C, (127)I] Altropane: a highly selective ligand for PET imaging of dopamine transporter sites.

Fischman AJ, Bonab AA, Babich JW, Livni E, Alpert NM, Meltzer PC, Madras BK.

Synapse. 2001 Mar 15;39(4):332-42.

PMID:
11169784
41.

Regional pharmacokinetics of orally administered PET tracers.

Fischman AJ, Bonab AA, Rubin RH.

Curr Pharm Des. 2000 Nov;6(16):1625-9.

PMID:
10974157
42.

Comparison of 4 methods for quantification of dopamine transporters by SPECT with [123I]IACFT.

Bonab AA, Fischman AJ, Alpert NM.

J Nucl Med. 2000 Jun;41(6):1086-92.

43.

Dopamine transporter density in patients with attention deficit hyperactivity disorder.

Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ.

Lancet. 1999 Dec 18-25;354(9196):2132-3.

PMID:
10609822
44.

Measurement of muscle protein synthesis by positron emission tomography with L-[methyl-11C]methionine: effects of transamination and transmethylation.

Carter EA, Yu YM, Alpert NM, Bonab AA, Tompkins RG, Fischman AJ.

J Trauma. 1999 Aug;47(2):341-5.

PMID:
10452471
45.

Concentration of dopamine transporters: to Bmax or not to Bmax?

Morris ED, Bonab AA, Alpert NM, Fischman AJ, Madras BK, Christian BT.

Synapse. 1999 May;32(2):136-40. No abstract available.

PMID:
10231133
46.

Loss of D2 receptor binding with age in rhesus monkeys: importance of correction for differences in striatal size.

Morris ED, Chefer SI, Lane MA, Muzic RF Jr, Wong DF, Dannals RF, Matochik JA, Bonab AA, Villemagne VL, Grant SJ, Ingram DK, Roth GS, London ED.

J Cereb Blood Flow Metab. 1999 Feb;19(2):218-29.

PMID:
10027777
47.

Positron emission tomographic analysis of central dopamine D1 receptor binding in normal subjects treated with the atypical neuroleptic, SDZ MAR 327.

Christian BT, Babich JW, Livni E, Alpert NM, Bonab AA, Munconi L, Polinski R, Rubin RH, Fischman AJ.

Int J Mol Med. 1998 Jan;1(1):243-7.

PMID:
9852226
48.

Pharmacokinetics of [18F]trovafloxacin in healthy human subjects studied with positron emission tomography.

Fischman AJ, Babich JW, Bonab AA, Alpert NM, Vincent J, Callahan RJ, Correia JA, Rubin RH.

Antimicrob Agents Chemother. 1998 Aug;42(8):2048-54.

49.

Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters.

Fischman AJ, Bonab AA, Babich JW, Palmer EP, Alpert NM, Elmaleh DR, Callahan RJ, Barrow SA, Graham W, Meltzer PC, Hanson RN, Madras BK.

Synapse. 1998 Jun;29(2):128-41.

PMID:
9593103
50.

Positron emission tomographic analysis of central 5-hydroxytryptamine2 receptor occupancy in healthy volunteers treated with the novel antipsychotic agent, ziprasidone.

Fischman AJ, Bonab AA, Babich JW, Alpert NM, Rauch SL, Elmaleh DR, Shoup TM, Williams SA, Rubin RH.

J Pharmacol Exp Ther. 1996 Nov;279(2):939-47.

PMID:
8930203

Supplemental Content

Loading ...
Support Center